pcDNA™4/TO 哺乳动物表达载体
Product Image
Invitrogen™

pcDNA™4/TO 哺乳动物表达载体

A Tetracycline-Regulated Expression System without Viral TransactivatorsThe T-REx™ System yields higher levels of induced expression than any other regulated mammalian了解更多信息
Have Questions?
货号数量
V102020
又称 V1020-20
20 μg
货号 V102020
又称 V1020-20
价格(CNY)
10,498.71
Online Exclusive
Ends: 31-Dec-2025
12,536.00
共减 2,037.29 (16%)
20 µg
添加至购物车
数量:
20 μg
价格(CNY)
10,498.71
Online Exclusive
Ends: 31-Dec-2025
12,536.00
共减 2,037.29 (16%)
20 µg
添加至购物车
A Tetracycline-Regulated Expression System without Viral Transactivators
The T-REx™ System yields higher levels of induced expression than any other regulated mammalian expression system. It utilizes the complete CMV promoter and adds control elements from the bacterial tetracycline resistance operon to effectively repress and derepress transcription from one of the strongest mammalian promoter sequences known (1,2).

Specific Activation
The T-REx™ System uses a repressor mechanism that blocks transcription from the powerful CMV promoter in the absence of tetracycline. Because the T-REx™ System elements do not use viral transactivators, you can achieve high-level expression from the complete CMV promoter without secondary, non-specific activation of host genes.

The T-REx™ Mechanism
The T-REx™ transcriptional control elements are illustrated in Figure 1. Two tetracycline operator sequences (TetO2) have been inserted between the TATA box of the CMV promoter and the transcriptional start site. The TetO2 sequence itself has no effect on expression. When the tetracycline repressor protein (TR) is present, it effectively binds the TetO2 sites and blocks transcription initiation. Tetracycline added to the culture medium binds to, and changes the conformation of, the TR protein. This change causes the TR protein to release the TetO2 sites, derepressing transcription from the CMV promoter. The result is high-level expression of the gene of interest (Figure 2). Expression levels can be modulated based on the tetracycline concentration and can be induced to levels that are achieved with constitutive CMV expression vectors.
T-REx™ is a powerful inducible mammalian expression system that allows you to regulate expression from the complete human cytomegalovirus (CMV) enhancer-promoter. T-REx™inducible expression vectors offer the following features:

• Complete CMV enhancer-promoter sequence containing two copies of the tetracycline operator TetO2 sequence for high-level regulated expression
• Zeocin™ or hygromycin resistance gene for effective selection of stable mammalian cell lines
• Large multiple cloning site to simplify cloning

In addition, pcDNA™4/TO/myc-His offers a c-myc epitope for rapid detection of the recombinant protein with an Anti-myc Antibody and a polyhistidine (6xHis) sequence for simple purification of the recombinant protein with nickel-chelating resin and detection with Anti- His(C-term) Antibody.

The regulatory vector, pcDNA™6/TR, is provided for high-level expression of the tetracycline repressor (TR) protein. This vector expresses the Blasticidin resistance gene for rapid selection of mammalian cell lines that stably express the TR protein.
仅供科研使用。不可用于诊断程序。
规格
构成或诱导系统诱导
输送类型转染
适用于(应用)调节表达
诱导剂四环素
产品类型哺乳动物表达载体
数量20 μg
选择试剂(真核生物)Zeocin™
载体pcDNA
克隆方法限制性内切酶/MCS
产品线T-REx、pcDNA, pcDNA
促进剂CMV/TO
蛋白标记未标记
Unit Size20 µg

常见问题解答 (FAQ)

我进行了稳转筛选,但我的抗生素耐受克隆中未表达我的目的基因。发生了什么问题?

这里列举了一些可能的原因与解决方案:

•所用检测法可能不适当或不够灵敏: ◦我们推荐您优化检测方案或寻找更为灵敏的方法。如果使用考马斯亮蓝染色/银染法检测过该蛋白,我们则推荐您使用免疫印迹法来增加检测灵敏度。裂解产物中存在的内源蛋白可能会在考马斯亮蓝染色/银染过程中掩盖目的蛋白。如果可能,我们推荐您在免疫印迹实验中包括一个阳性对照。
•筛选到的克隆数不够:至少筛选出20个克隆。
•在稳转筛选中使用了不适当的抗生素浓度:请确保正确获取了抗生素的杀死曲线。由于某一既定抗生素的效力依赖于细胞类型,血清,培养基和培养技术,因此必须在每次进行稳定筛选的时候确定抗生素的用量。如果采用的培养基或血清条件明显不同,则即使是我们所提供的稳转细胞系对于我们推荐的剂量也可能出现更敏感或更不敏感的情况。
•基因产物(即使低水平)的表达可能与该细胞系的生长不相容(如毒性基因):使用一个可诱导的表达系统。
•阴性克隆可能由基因表达的关键载体位点处优先发生了线性化所致:在一个不影响表达的位点实施载体线性化,如在细菌抗药性标志物序列中。

我正在使用一款哺乳动物表达载体,但未成功表达我的蛋白。你们能帮我解决这一难题么?

这里列举了一些可能的原因与解决方案:

•尝试试剂盒自带的表达对照。
•可能的检测问题:
◦检测瞬转的表达蛋白可能有难度,因为转染效率可能过低,以致用于整个转染群体的评估手段无法成功实现检测。我们推荐您通过稳转筛选或采用能够逐个检测单一细胞的技术手段来优化您的转染操作。您也可尝试通过改变启动子或细胞类型来提高表达水平。
◦细胞中的蛋白表达水平对于所选择的检测方法来说可能过低。我们推荐您优化检测方案或寻找更为灵敏的方法。如果使用考马斯亮蓝染色/银染法检测过该蛋白,我们则推荐您使用免疫印迹法来增加检测灵敏度。裂解产物中存在的内源蛋白可能会在考马斯亮蓝染色/银染过程中掩盖目的蛋白。如果可能,我们推荐您在免疫印迹实验中包括一个阳性对照。
◾蛋白可能降解或截短了:使用Northern杂交进行检测。
◾可能的时程问题:由于蛋白表达随时间延长而发生的变化依赖该蛋白的天然属性,我们一般推荐您先获取一份表达的时程曲线。尝试进行一次时程分析将帮助您确定最优的表达时间窗。
◾可能的克隆问题:通过限制性酶切和/或测序来验证克隆。

我正在使用一个包含新霉素抗性基因的哺乳动物表达载体。我能否在哺乳动物细胞中使用新霉素进行稳转筛选?

不可以;新霉素对哺乳动物细胞有毒性。我们推荐您使用Geneticin(又称 G418硫酸盐),这一产品的毒性较低,是在哺乳动物细胞中进行有效筛选的新霉素的替代品。

我构建的载体中,目的基因的ATG前方还有另一个ATG,这样可以么?它会干扰我基因的翻译么?

即使缺乏Kozak序列,翻译也还是会在核糖体遇到的第一个ATG处启始,不过启始效率可能相对较低。只要处于最初ATG的阅读框内,任何下游的插入序列都可能表达为融合蛋白,不过如果这里没有Kozak保守序列,则蛋白的表达水平预期会比较低。如果载体中包含一个非Kozak型的保守ATG,我们则推荐您将基因克隆至该ATG上游,再包含一个Kozak序列来优化表达效果。 

你们是否提供表达GFP的哺乳动物载体,这样我就可将其作为参照来监测我的转染和表达情况?

我们提供pJTI R4 Exp CMV EmGFP pA载体,货号A14146,您可使用这一产品来监控转染和表达情况。

引用和文献 (5)

引用和文献
Abstract
Retention of mutant low density lipoprotein receptor in ER leads to ER stress.
Authors:Sørensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA,
Journal:J Biol Chem
PubMed ID:16257961
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the gene encoding the low density lipoprotein receptor (LDLR). More than 50% of these mutations lead to receptor proteins that are completely or partly retained in the endoplasmic reticulum (ER). The mechanisms involved in the intracellular processing and ... More
BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts.
Authors:Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, Gross A,
Journal:J Biol Chem
PubMed ID:12519725
The proapoptotic activity of BID seems to solely depend upon its cleavage to truncated tBID. Here we demonstrate that expression of a caspase-8 non-cleavable (nc) BID-D59A mutant or expression of wild type (wt) BID induces apoptosis in Bid -/-, caspase-8 -/-, and wt primary MEFs. Western blot analysis indicated that ... More
Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Calpha.
Authors:Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S,
Journal:J Biol Chem
PubMed ID:12514180
Protein phosphatase 2C (PP2C) dephosphorylates a broad range of substrates, regulating stress response and growth-related pathways in both prokaryotes and eukaryotes. We now demonstrate that PP2Calpha, a major mammalian isoform, inhibits cell growth and activates the p53 pathway. In 293 cell clones, in which PP2Calpha expression is regulated by a ... More
The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus.
Authors: Gao Y; Pimplikar S W;
Journal:Proc Natl Acad Sci U S A
PubMed ID:11742091
Sequential processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates the Abeta peptide, a major constituent of the senile plaques observed in Alzheimer's disease. The cleavage by gamma-secretase also results in the cytoplasmic release of a 59- or 57-residue-long C-terminal fragment (Cgamma). This processing resembles regulated intramembrane ... More
ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.
Authors: Nghiem Paul; Park Peter K; Kim Ys Yong-son; Desai Bimal N; Schreiber Stuart L;
Journal:J Biol Chem
PubMed ID:11711532
ATR (ataxia telangiectasia and Rad-3-related) is a protein kinase required for survival after DNA damage. A critical role for ATR has been hypothesized to be the regulation of p53 and other cell cycle checkpoints. ATR has been shown to phosphorylate p53 at Ser(15), and this damage-induced phosphorylation is diminished by ... More